We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Israeli COVID vaccine in pill form to start clinical trial in Tel Aviv

3 0 0
22.07.2021

A prospective oral coronavirus vaccine is set to start clinical trials in Israel, and the developer believes it could help get vaccines to countries that are struggling to inoculate because of limited infrastructure.

Oramed Pharmaceuticals has created a single-dose oral version of a prospective vaccine being developed by India-based Premas Biotech, and in March announced that it had successfully generated antibodies in pigs.

It hopes that the Israeli-developed pill will be suitable as a simple initial vaccination, as it won’t need to be stored at low temperatures and eliminates the need to have professionals administering injections.

This could be a “game changer” in countries like India, where only 5 percent of the population has been vaccinated, said Nadav Kidron, CEO of Oramed.

He anticipates the technology could help healthcare providers meet the possible challenge of providing booster shots — increasingly........

© The Times of Israel


Get it on Google Play